标题
Trial Watch
作者
关键词
-
出版物
OncoImmunology
Volume 1, Issue 5, Pages 699-739
出版商
Informa UK Limited
发表日期
2012-07-11
DOI
10.4161/onci.20696
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Administration of a Synthetic TLR4 Agonist Protects Mice from Pneumonic Tularemia
- (2014) A. Lembo et al. JOURNAL OF IMMUNOLOGY
- Heat Shock Protein 70, Released from Heat-Stressed Tumor Cells, Initiates Antitumor Immunity by Inducing Tumor Cell Chemokine Production and Activating Dendritic Cells via TLR4 Pathway
- (2014) T. Chen et al. JOURNAL OF IMMUNOLOGY
- Premortem autophagy determines the immunogenicity of chemotherapy-induced cancer cell death
- (2012) Isabelle Martins et al. Autophagy
- Safety and Immunogenicity of Vaccination With MART-1 (26–35, 27L), gp100 (209–217, 210M), and Tyrosinase (368–376, 370D) In Adjuvant With PF-3512676 and GM-CSF In Metastatic Melanoma
- (2012) Ahmad A. Tarhini et al. JOURNAL OF IMMUNOTHERAPY
- The secret ally: immunostimulation by anticancer drugs
- (2012) Lorenzo Galluzzi et al. NATURE REVIEWS DRUG DISCOVERY
- Modulating immunity as a therapy for bacterial infections
- (2012) Robert E. W. Hancock et al. NATURE REVIEWS MICROBIOLOGY
- Toll-like receptor 3 signaling converts tumor-supporting myeloid cells to tumoricidal effectors
- (2012) H. Shime et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Structural Basis of TLR5-Flagellin Recognition and Signaling
- (2012) S.-i. Yoon et al. SCIENCE
- The Structure of the TLR5-Flagellin Complex: A New Mode of Pathogen Detection, Conserved Receptor Dimerization for Signaling
- (2012) J. Lu et al. Science Signaling
- Trial Watch: Monoclonal antibodies in cancer therapy
- (2012) Lorenzo Galluzzi et al. OncoImmunology
- Trial watch
- (2012) Erika Vacchelli et al. OncoImmunology
- An intra-patient placebo-controlled phase I trial to evaluate the safety and tolerability of intradermal IMM-101 in melanoma
- (2011) J. Stebbing et al. ANNALS OF ONCOLOGY
- A phase III randomized study of gemcitabine and cisplatin with or without PF-3512676 (TLR9 agonist) as first-line treatment of advanced non-small-cell lung cancer
- (2011) C. Manegold et al. ANNALS OF ONCOLOGY
- Anticancer function of polyinosinic-polycytidylic acid
- (2011) Yu-sheng Cheng et al. CANCER BIOLOGY & THERAPY
- Mycobacteria activate γδ T-cell anti-tumour responses via cytokines from type 1 myeloid dendritic cells: a mechanism of action for cancer immunotherapy
- (2011) Daniel W. Fowler et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Prerequisites for the Antitumor Vaccine-Like Effect of Chemotherapy and Radiotherapy
- (2011) Dalil Hannani et al. CANCER JOURNAL
- Systemic Cancer Therapy with a Small Molecule Agonist of Toll-like Receptor 7 Can Be Improved by Circumventing TLR Tolerance
- (2011) C. Bourquin et al. CANCER RESEARCH
- TLR3 as a Biomarker for the Therapeutic Efficacy of Double-stranded RNA in Breast Cancer
- (2011) B. Salaun et al. CANCER RESEARCH
- Disruption of the PP1/GADD34 complex induces calreticulin exposure
- (2011) Oliver Kepp et al. CELL CYCLE
- Molecular definitions of cell death subroutines: recommendations of the Nomenclature Committee on Cell Death 2012
- (2011) L Galluzzi et al. CELL DEATH AND DIFFERENTIATION
- EGFR-Homing dsRNA Activates Cancer-Targeted Immune Response and Eliminates Disseminated EGFR-Overexpressing Tumors in Mice
- (2011) A. Shir et al. CLINICAL CANCER RESEARCH
- Phase I Study Utilizing a Novel Antigen-Presenting Cell-Targeted Vaccine with Toll-like Receptor Stimulation to Induce Immunity to Self-antigens in Cancer Patients
- (2011) M. A. Morse et al. CLINICAL CANCER RESEARCH
- Intratumoral Administration of TLR4 Agonist Absorbed into a Cellular Vector Improves Antitumor Responses
- (2011) M. B. Davis et al. CLINICAL CANCER RESEARCH
- VTX-2337 Is a Novel TLR8 Agonist That Activates NK Cells and Augments ADCC
- (2011) H. Lu et al. CLINICAL CANCER RESEARCH
- CDX-1307: a novel vaccine under study as treatment for muscle-invasive bladder cancer
- (2011) Michael A Morse et al. Expert Review of Vaccines
- Immunotherapeutic efficacy of Mycobacterium indicus pranii in eliciting anti-tumor T cell responses: Critical roles of IFNγ
- (2011) Srabanti Rakshit et al. INTERNATIONAL JOURNAL OF CANCER
- Toll-like Receptor 5 Agonist Protects Mice From Dermatitis and Oral Mucositis Caused by Local Radiation: Implications for Head-and-Neck Cancer Radiotherapy
- (2011) Lyudmila G. Burdelya et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Randomized Phase III Trial of Paclitaxel/Carboplatin With or Without PF-3512676 (Toll-Like Receptor 9 Agonist) As First-Line Treatment for Advanced Non–Small-Cell Lung Cancer
- (2011) Vera Hirsh et al. JOURNAL OF CLINICAL ONCOLOGY
- A TLR5 Agonist Inhibits Acute Renal Ischemic Failure
- (2011) N. Fukuzawa et al. JOURNAL OF IMMUNOLOGY
- Absence of MyD88 Results in Enhanced TLR3-Dependent Phosphorylation of IRF3 and Increased IFN- and RANTES Production
- (2011) J. Siednienko et al. JOURNAL OF IMMUNOLOGY
- Mycobacterial Strains That Stimulate the Immune System Most Efficiently as Candidates for the Treatment of Bladder Cancer
- (2011) Zehra Stara Yuksel et al. JOURNAL OF MOLECULAR MICROBIOLOGY AND BIOTECHNOLOGY
- Phase I clinical trial of CpG oligonucleotide 7909 (PF-03512676) in patients with previously treated chronic lymphocytic leukemia
- (2011) Clive S. Zent et al. LEUKEMIA & LYMPHOMA
- Prophylactic vaccines mimic synthetic CpG oligonucleotides in their ability to modulate immune responses
- (2011) I. Jolanda M. de Vries et al. MOLECULAR IMMUNOLOGY
- Intracerebral administration of CpG oligonucleotide for patients with recurrent glioblastoma: a phase II study
- (2011) A. Carpentier et al. NEURO-ONCOLOGY
- TLR2-Dependent Induction of IL-10 and Foxp3+CD25+CD4+ Regulatory T Cells Prevents Effective Anti-Tumor Immunity Induced by Pam2 Lipopeptides In Vivo
- (2011) Sayuri Yamazaki et al. PLoS One
- Activation of Anti-Tumor Immune Response and Reduction of Regulatory T Cells with Mycobacterium indicus pranii (MIP) Therapy in Tumor Bearing Mice
- (2011) Faiz Ahmad et al. PLoS One
- Autophagy-Dependent Anticancer Immune Responses Induced by Chemotherapeutic Agents in Mice
- (2011) M. Michaud et al. SCIENCE
- Safety and immunogenicity of a recombinant M2e–flagellin influenza vaccine (STF2.4xM2e) in healthy adults
- (2011) Christine B. Turley et al. VACCINE
- Commonly used prophylactic vaccines as an alternative for synthetically produced TLR ligands to mature monocyte-derived dendritic cells
- (2010) G. Schreibelt et al. BLOOD
- Toll-like receptor 9 signaling by CpG-B oligodeoxynucleotides induces an apoptotic pathway in human chronic lymphocytic leukemia B cells
- (2010) X. Liang et al. BLOOD
- Potentiation of the antitumor effects of imidazoquinoline immune response modifiers by cyclophosphamide
- (2010) Calin D. Dumitru et al. CANCER BIOLOGY & THERAPY
- Toll-like receptor-7 agonist administered subcutaneously in a prolonged dosing schedule in heavily pretreated recurrent breast, ovarian, and cervix cancers
- (2010) Melissa A. Geller et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Toll-like Receptor 3–Mediated Suppression of TRAMP Prostate Cancer Shows the Critical Role of Type I Interferons in Tumor Immune Surveillance
- (2010) Arnold I. Chin et al. CANCER RESEARCH
- Opposing Effects of Toll-like Receptor (TLR3) Signaling in Tumors Can Be Therapeutically Uncoupled to Optimize the Anticancer Efficacy of TLR3 Ligands
- (2010) R. Conforti et al. CANCER RESEARCH
- Vaccination with peptides derived from cancer-testis antigens in combination with CpG-7909 elicits strong specific CD8+ T cell response in patients with metastatic esophageal squamous cell carcinoma
- (2010) Makoto Iwahashi et al. CANCER SCIENCE
- Decoding Cell Death Signals in Inflammation and Immunity
- (2010) Laurence Zitvogel et al. CELL
- Chemotherapy induces ATP release from tumor cells
- (2010) Isabelle Martins et al. CELL CYCLE
- Survival of Patients with Newly Diagnosed Glioblastoma Treated with Radiation and Temozolomide in Research Studies in the United States
- (2010) S. A. Grossman et al. CLINICAL CANCER RESEARCH
- Efficient In vivo Priming by Vaccination with Recombinant NY-ESO-1 Protein and CpG in Antigen Naive Prostate Cancer Patients
- (2010) J. Karbach et al. CLINICAL CANCER RESEARCH
- TLR3-mediated IFN-β gene induction is negatively regulated by the TLR adaptor MyD88 adaptor-like
- (2010) Jakub Siednienko et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- A Novel Toll-like Receptor That Recognizes Vesicular Stomatitis Virus
- (2010) Zhongcheng Shi et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- UNC93B1 Is Essential for TLR11 Activation and IL-12-dependent Host Resistance toToxoplasma gondii
- (2010) Reed Pifer et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Triggering of TLR7 and TLR8 expressed by human lung cancer cells induces cell survival and chemoresistance
- (2010) Julien Cherfils-Vicini et al. JOURNAL OF CLINICAL INVESTIGATION
- In Situ Vaccination With a TLR9 Agonist Induces Systemic Lymphoma Regression: A Phase I/II Study
- (2010) Joshua D. Brody et al. JOURNAL OF CLINICAL ONCOLOGY
- Human TLRs 10 and 1 Share Common Mechanisms of Innate Immune Sensing but Not Signaling
- (2010) Y. Guan et al. JOURNAL OF IMMUNOLOGY
- Phase I trial of a Toll-like receptor 9 agonist, PF-3512676 (CPG 7909), in patients with treatment-refractory, cutaneous T-cell lymphoma
- (2010) Youn H. Kim et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Targeting Toll-like receptors: emerging therapeutics?
- (2010) Elizabeth J. Hennessy et al. NATURE REVIEWS DRUG DISCOVERY
- A multi-institution phase II study of poly-ICLC and radiotherapy with concurrent and adjuvant temozolomide in adults with newly diagnosed glioblastoma
- (2010) M. R. Rosenfeld et al. NEURO-ONCOLOGY
- Molecular Modeling-Based Evaluation of hTLR10 and Identification of Potential Ligands in Toll-Like Receptor Signaling
- (2010) Rajiv Gandhi Govindaraj et al. PLoS One
- Immunopotentiation of Trivalent Influenza Vaccine When Given with VAX102, a Recombinant Influenza M2e Vaccine Fused to the TLR5 Ligand Flagellin
- (2010) H. Keipp Talbot et al. PLoS One
- Identification of a Primary Target of Thalidomide Teratogenicity
- (2010) T. Ito et al. SCIENCE
- Brain Tumor Immunotherapy with Type-1 Polarizing Strategies
- (2009) Hideho Okada Annals of the New York Academy of Sciences
- Phase II study of a TLR-9 agonist (1018 ISS) with rituximab in patients with relapsed or refractory follicular lymphoma
- (2009) Jonathan W. Friedberg et al. BRITISH JOURNAL OF HAEMATOLOGY
- Randomized phase 2/3 trial of CpG oligodeoxynucleotide PF-3512676 alone or with dacarbazine for patients with unresectable stage III and IV melanoma
- (2009) Jeffrey S. Weber et al. CANCER
- Phase I study of TLR9 agonist PF-3512676 in combination with carboplatin and paclitaxel in patients with advanced non-small-cell lung cancer
- (2009) Kazuhiko Yamada et al. CANCER SCIENCE
- A Novel Toll-Like Receptor 9 Agonist Cooperates with Trastuzumab in Trastuzumab-Resistant Breast Tumors through Multiple Mechanisms of Action
- (2009) V. Damiano et al. CLINICAL CANCER RESEARCH
- Safety and Efficacy of PF-3512676 for the Treatment of Stage IV Renal Cell Carcinoma: An Open-Label, Multicenter Phase I/II Study
- (2009) John A. Thompson et al. Clinical Genitourinary Cancer
- The Common Mycobacterial Antigens and their Importance in the Treatment of Disease
- (2009) John Stanford et al. CURRENT PHARMACEUTICAL DESIGN
- Recognition of Lipopeptide Patterns by Toll-like Receptor 2-Toll-like Receptor 6 Heterodimer
- (2009) Jin Young Kang et al. IMMUNITY
- Topical resiquimod promotes priming of CTL to parenteral antigens
- (2009) Brent A. Chang et al. VACCINE
- A phase II dose-ranging study of topical resiquimod to treat actinic keratosis
- (2008) R.-M. Szeimies et al. BRITISH JOURNAL OF DERMATOLOGY
- Paclitaxel reduces regulatory T cell numbers and inhibitory function and enhances the anti-tumor effects of the TLR9 agonist PF-3512676 in the mouse
- (2008) Alain P. Vicari et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Toll-like receptors expressed in tumor cells: targets for therapy
- (2008) Li Yu et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Activation of Toll-like receptor 2 by a novel preparation of cell wall skeleton from Mycobacterium bovis BCG Tokyo (SMP-105) sufficiently enhances immune responses against tumors
- (2008) Masashi Murata CANCER SCIENCE
- Local Administration of PF-3512676 CpG-B Instigates Tumor-Specific CD8+ T-Cell Reactivity in Melanoma Patients
- (2008) B. G. Molenkamp et al. CLINICAL CANCER RESEARCH
- An Exploratory Study of Systemic Administration of the Toll-like Receptor-7 Agonist 852A in Patients with Refractory Metastatic Melanoma
- (2008) R. Dummer et al. CLINICAL CANCER RESEARCH
- CPG 7909 Adjuvant plus Hepatitis B Virus Vaccination in HIV‐Infected Adults Achieves Long‐Term Seroprotection for Up to 5 Years
- (2008) C. L. Cooper et al. CLINICAL INFECTIOUS DISEASES
- An evaluation of a preparation of Mycobacterium vaccae (SRL172) as an immunotherapeutic agent in renal cancer
- (2008) P.M. Patel et al. EUROPEAN JOURNAL OF CANCER
- Randomized Phase II Trial of a Toll-Like Receptor 9 Agonist Oligodeoxynucleotide, PF-3512676, in Combination With First-Line Taxane Plus Platinum Chemotherapy for Advanced-Stage Non–Small-Cell Lung Cancer
- (2008) Christian Manegold et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase 1 Evaluation of Intralesionally Injected TLR9-agonist PF-3512676 in Patients With Basal Cell Carcinoma or Metastatic Melanoma
- (2008) Maja A. Hofmann et al. JOURNAL OF IMMUNOTHERAPY
- TLR7 Agonist 852A Inhibition of Tumor Cell Proliferation Is Dependent on Plasmacytoid Dendritic Cells and Type I IFN
- (2008) Jon R. Inglefield et al. JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
- A North American brain tumor consortium phase II study of poly-ICLC for adult patients with recurrent anaplastic gliomas
- (2008) Nicholas Butowski et al. JOURNAL OF NEURO-ONCOLOGY
- A phase II clinical trial of poly-ICLC with radiation for adult patients with newly diagnosed supratentorial glioblastoma: a North American Brain Tumor Consortium (NABTC01-05)
- (2008) Nicholas Butowski et al. JOURNAL OF NEURO-ONCOLOGY
- Expression and distribution of Toll-like receptors 11–13 in the brain during murine neurocysticercosis
- (2008) Bibhuti B Mishra et al. Journal of Neuroinflammation
- Sequence- and target-independent angiogenesis suppression by siRNA via TLR3
- (2008) Mark E. Kleinman et al. NATURE
- Toll-like receptor 9 (TLR9) agonists in the treatment of cancer
- (2008) A M Krieg ONCOGENE
- An Agonist of Toll-Like Receptor 5 Has Radioprotective Activity in Mouse and Primate Models
- (2008) L. G. Burdelya et al. SCIENCE
- Structural Basis of Toll-Like Receptor 3 Signaling with Double-Stranded RNA
- (2008) L. Liu et al. SCIENCE
- Anti-tumor effect of DNA-based vaccination and dSLIM immunomodulatory molecules in mice with Ph+ acute lymphoblastic leukaemia
- (2008) Joachim Köchling et al. VACCINE
- A clinical grade poly I:C-analogue (Ampligen®) promotes optimal DC maturation and Th1-type T cell responses of healthy donors and cancer patients in vitro
- (2008) H. Navabi et al. VACCINE
- Successful immunotherapy with Mycobacterium vaccae in the treatment of adenocarcinoma of the lung
- (2007) J.L. Stanford et al. EUROPEAN JOURNAL OF CANCER
- Comprehensive analysis of mycolic acid subclass and molecular species composition of Mycobacterium bovis BCG Tokyo 172 cell wall skeleton (SMP-105)
- (2007) Yuko Uenishi et al. JOURNAL OF MICROBIOLOGICAL METHODS
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now